Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00053053 · ClinicalTrials.gov registry record · Phase 3
Comparison of Nutritional Supplements in Preventing Weight Loss in Patients With Cancer
A Phase 3 study of Lymphoma and Unspecified Adult Solid Tumor, Protocol Specific, sponsored by Radiation Therapy Oncology Group.
- Completed
- Registry status
- Phase 3
- Development phase
- 472
- Enrollment target
- 20
- Study locations
NCT00053053: Completed Phase 3 study of Lymphoma and Unspecified Adult Solid Tumor, Protocol Specific, sponsored by Radiation Therapy Oncology Group.
NCT00053053 is a Phase 3 study of Lymphoma and Unspecified Adult Solid Tumor, Protocol Specific that has completed, run by Radiation Therapy Oncology Group. The registered enrollment target is 472 participants, roughly in line with the 482-participant average among 299 other Lymphoma trials with a reported enrollment target. The trial reports 20 study locations across 3 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00053053, a Phase 3 study of Lymphoma and Unspecified Adult Solid Tumor, Protocol Specific, has completed, sponsored by Radiation Therapy Oncology Group.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 472 participants
- Enrollment target
- 20
- Study locations
Study Summary
RATIONALE: Nutritional supplements may help prevent loss of appetite, weight loss, and fatigue in patients with advanced cancer. PURPOSE: Randomized phase III trial to compare the effectiveness of two nutritional supplements in preventing loss of appetite, weight loss, and fatigue in patients who have stage III or stage IV solid tumors.
Conditions Studied
Interventions
- DIETARY_SUPPLEMENT Juven
- DIETARY_SUPPLEMENT Non-Juven Supplement
Study Locations (20)
California
- Providence Saint Joseph Medical Center - Burbank - Burbank
- Mount Diablo Regional Cancer Center - Concord
- City of Hope Comprehensive Cancer Center - Duarte
- California Cancer Center - Woodward Park Office - Fresno
- Saint Agnes Cancer Center - Fresno
- Sutter Health Western Division Cancer Research Group - Greenbrae
- Loma Linda University Cancer Institute at Loma Linda University Medical Center - Loma Linda
- Veterans Affairs Medical Center - Long Beach - Long Beach
- USC/Norris Comprehensive Cancer Center and Hospital - Los Angeles
- Jonsson Comprehensive Cancer Center at UCLA - Los Angeles
- CCOP - Bay Area Tumor Institute - Oakland
- Huntington Cancer Center at Huntington Hospital - Pasadena
- Robert and Beverly Lewis Family Cancer Care Center at Pomona Valley Hospital Medical Center - Pomona
- Radiation Oncology Centers - Sacramento - Sacramento
Alabama
- Comprehensive Cancer Center at University of Alabama at Birmingham - Birmingham
- Comprehensive Cancer Institute - Huntsville
- MBCCOP - Gulf Coast - Mobile
- Montgomery Cancer Center - Montgomery
- DCH Cancer Treatment Center - Tuscaloosa
Arizona
- Foundation for Cancer Research and Education - Phoenix
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 472 participants |
| Start Date | 2002-12 |
| Est. Completion | 2009-02 |
| Phase | Phase 3 |
What the finished NCT00053053 record still lists
NCT00053053 is an interventional study that assigns participants to a tested intervention. The registered 472 participants enrollment target is mid-sized for trials with a published cap, roughly in line with the 482-participant average among 299 other Lymphoma trials with a reported enrollment target.
The record links to 4 conditions, with Lymphoma appearing as the primary indexed condition, and to 2 interventions - of which Juven is the first listed.
NCT00053053 names 20 study sites across 3 states, led by California, Alabama, Arizona.
Frequently Asked Questions
What is clinical trial NCT00053053 about?
NCT00053053 is a clinical study titled "Comparison of Nutritional Supplements in Preventing Weight Loss in Patients With Cancer". RATIONALE: Nutritional supplements may help prevent loss of appetite, weight loss, and fatigue in patients with advanced cancer. PURPOSE: Randomized phase III trial to compare the effectiveness of two nutritional supplements in preventing loss of appetite, weight loss, and fatigue in patients who h...
What is the current status of trial NCT00053053?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 472 participants. The study started on 2002-12. Estimated completion is 2009-02.
What conditions does trial NCT00053053 study?
This clinical trial studies the following conditions: Lymphoma, Unspecified Adult Solid Tumor, Protocol Specific, Cachexia, Lymphoproliferative Disorder.
What interventions are being tested in trial NCT00053053?
The interventions under investigation include: Juven (DIETARY_SUPPLEMENT), Non-Juven Supplement (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT00053053?
This trial is sponsored by Radiation Therapy Oncology Group, which has 144 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00053053 being conducted?
This trial has 20 study locations across Alabama, Arizona, California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Lymphoma
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00053053's enrollment target sits among peer trials
472 20th of 299 higher than 280 of 299 other Lymphoma trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Lymphoma trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
A Study to Evaluate Glofitamab as a Single Agent vs. Investigator's Choice in Participants With Relapsed/Refractory Mantle Cell Lymphoma
RECRUITING · Phase 3
-
Geriatric Evaluation and Management With Survivorship Health Education for Older Survivors of Cancer, GEM-S Trial
RECRUITING · Phase 3
-
Post-Op Pain Control for Prophylactic Intramedullary Nailing.
RECRUITING · Phase 3
-
Haploidentical Allogeneic Peripheral Blood Transplantation: Examining Checkpoint Immune Regulators' Expression
ACTIVE NOT RECRUITING · Phase 3
-
Lactobacillus Plantarum in Preventing Acute Graft Versus Host Disease in Children Undergoing Donor Stem Cell Transplant
ACTIVE NOT RECRUITING · Phase 3
-
Epoetin Alfa in Treating Anemia in Patients With Lymphoma, Chronic Lymphocytic Leukemia, or Multiple Myeloma and Anemia Caused By Chemotherapy
COMPLETED · Phase 3
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06375083 · 472 participants · Phase 2
Computerized Cognitive Behavioral Therapies for Suicide Prevention and Depression
- NCT06947187 · 472 participants · NA
Vaccine Confidence and Infodemic in Southeast Asia's Nusantara Sociocultural Sphere
- NCT07199517 · 472 participants · NA
Catalyzing Cigarette Smoking Cessation Through Harm Reduction Sampling Among People Unmotivated to Quit
- NCT07225881 · 472 participants · NA
Eatwell Clinical Trial (R01)
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia